Previous Close | 1.8280 |
Open | 1.8700 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.8040 - 1.8700 |
52 Week Range | 0.8880 - 3.4400 |
Volume | |
Avg. Volume | 42,948 |
Market Cap | 183.773M |
Beta (5Y Monthly) | 3.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.1300 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.02 |
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting rights09/30/2024100,093,87388,569,683 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46
CERVOMED INC (CRVO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.